Cargando…
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common malignant tumour, which has a poor prognosis. Surgical resection can be curative but most patients are inoperable and most chemotherapy agents have minimal activity in this disease. Seocalcitol, a vitamin D analogue, induces differentiation and inhibits gro...
Autores principales: | Dalhoff, K, Dancey, J, Astrup, L, Skovsgaard, T, Hamberg, K J, Lofts, F J, Rosmorduc, O, Erlinger, S, Bach Hansen, J, Steward, W P, Skov, T, Burcharth, F, Evans, T R J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394267/ https://www.ncbi.nlm.nih.gov/pubmed/12865912 http://dx.doi.org/10.1038/sj.bjc.6601104 |
Ejemplares similares
-
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer
por: Evans, T R J, et al.
Publicado: (2002) -
Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?
por: Gogas, H., et al.
Publicado: (1998) -
A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
por: Evans, T. R., et al.
Publicado: (1996) -
Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications.
por: Sørensen, J. B., et al.
Publicado: (1989) -
Inoperable Cancer
Publicado: (1901)